Morbihan Disease Treatment: Two Case Reports and a Systematic Literature Review. Issue 2 (March 2019)
- Record Type:
- Journal Article
- Title:
- Morbihan Disease Treatment: Two Case Reports and a Systematic Literature Review. Issue 2 (March 2019)
- Main Title:
- Morbihan Disease Treatment
- Authors:
- Boparai, Ranjodh S.
Levin, Ariana M.
Lelli, Gary J. - Abstract:
- Abstract : Purpose: To assess the effectiveness of treatments for Morbihan disease. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the literature was performed on April 1, 2018, using PubMed, Google Scholar, and Excerpta Medica dataBASE with terms used to describe Morbihan disease, including "Morbihan Disease, " "Morbihan Syndrome, " "lymphedema rosacea, " and "lymphedematous rosacea". Case reports or case series were included if they fulfilled the following criteria: published in English, peer-reviewed, and reported Morbihan disease. Results: A total of 89 patients—87 patients from 49 articles and 2 cases from the authors' institution—were included in the final analysis. The median age of patients was 51 years (range: 14–79), and 66 of 89 (74%) patients were men. Male gender correlated with lack of complete response to treatment (odds ratio: 0.25; 95% confidence interval: 0.06–0.97; p = 0.02), while presence of papules or pustules correlated with complete response to treatment (odds ratio: 4.07; 95% confidence interval: 1.04–17.68; p = 0.03). Longer antibiotic duration correlated with response to treatment ( p = 0.03), favoring complete over partial response ( p = 0.02). Mean antibiotic duration in patients who responded was 4.43 months (standard deviation: 3.49), with complete responders requiring 6.50 months (standard deviation: 4.57). Oral corticosteroids, isotretinoins, and combinationAbstract : Purpose: To assess the effectiveness of treatments for Morbihan disease. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the literature was performed on April 1, 2018, using PubMed, Google Scholar, and Excerpta Medica dataBASE with terms used to describe Morbihan disease, including "Morbihan Disease, " "Morbihan Syndrome, " "lymphedema rosacea, " and "lymphedematous rosacea". Case reports or case series were included if they fulfilled the following criteria: published in English, peer-reviewed, and reported Morbihan disease. Results: A total of 89 patients—87 patients from 49 articles and 2 cases from the authors' institution—were included in the final analysis. The median age of patients was 51 years (range: 14–79), and 66 of 89 (74%) patients were men. Male gender correlated with lack of complete response to treatment (odds ratio: 0.25; 95% confidence interval: 0.06–0.97; p = 0.02), while presence of papules or pustules correlated with complete response to treatment (odds ratio: 4.07; 95% confidence interval: 1.04–17.68; p = 0.03). Longer antibiotic duration correlated with response to treatment ( p = 0.03), favoring complete over partial response ( p = 0.02). Mean antibiotic duration in patients who responded was 4.43 months (standard deviation: 3.49), with complete responders requiring 6.50 months (standard deviation: 4.57). Oral corticosteroids, isotretinoins, and combination therapies did not correlate with treatment response. Conclusions: The presence of papules and pustules correlates with a complete response to treatment, while male gender correlates with a partial response. Patients may benefit from 4- to 6-month duration of tetracycline-based antibiotics. Prospective studies are needed to assess the impact of antibiotic and isotretinoin dose and duration on treatment response. Abstract : In this systematic review, 4- to 6-month duration of tetracycline-based antibiotics correlated with response to treatment, favoring complete over partial response. Other commonly used treatments, including oral corticosteroids, isotretinoins, and combination therapies did not correlate with treatment response. … (more)
- Is Part Of:
- Ophthalmic plastic and reconstructive surgery. Volume 35:Issue 2(2019)
- Journal:
- Ophthalmic plastic and reconstructive surgery
- Issue:
- Volume 35:Issue 2(2019)
- Issue Display:
- Volume 35, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 35
- Issue:
- 2
- Issue Sort Value:
- 2019-0035-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-03
- Subjects:
- Eye -- Surgery -- Periodicals
Ophthalmic plastic surgery -- Periodicals
Reconstructive Surgical Procedures -- Periodicals
Ophthalmologic Surgical Procedures -- Periodicals
Ophthalmology -- Periodicals
Surgery -- Periodicals
617.70592 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00002341-000000000-00000 ↗
http://www.op-rs.com ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/IOP.0000000000001229 ↗
- Languages:
- English
- ISSNs:
- 0740-9303
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6271.430000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11752.xml